Doximity, Inc.
DOCS
$19.39
-$0.47-2.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 644.86M | 637.78M | 621.33M | 589.64M | 570.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 644.86M | 637.78M | 621.33M | 589.64M | 570.40M |
| Cost of Revenue | 70.33M | 65.39M | 60.87M | 58.12M | 55.87M |
| Gross Profit | 574.54M | 572.39M | 560.46M | 531.52M | 514.53M |
| SG&A Expenses | 220.84M | 215.53M | 207.73M | 195.04M | 190.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 421.87M | 397.31M | 372.82M | 350.42M | 339.62M |
| Operating Income | 222.99M | 240.47M | 248.51M | 239.21M | 230.78M |
| Income Before Tax | 250.01M | 276.28M | 285.32M | 274.55M | 263.57M |
| Income Tax Expenses | 53.95M | 36.88M | 32.29M | 39.42M | 40.39M |
| Earnings from Continuing Operations | 196.05 | 239.40 | 253.03 | 235.13 | 223.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 196.05M | 239.40M | 253.03M | 235.13M | 223.19M |
| EBIT | 222.99M | 240.47M | 248.51M | 239.21M | 230.78M |
| EBITDA | 229.98M | 246.65M | 253.75M | 243.91M | 235.64M |
| EPS Basic | 1.05 | 1.27 | 1.35 | 1.25 | 1.19 |
| Normalized Basic EPS | 0.86 | 0.92 | 0.96 | 0.92 | 0.89 |
| EPS Diluted | 0.99 | 1.20 | 1.26 | 1.17 | 1.11 |
| Normalized Diluted EPS | 0.81 | 0.86 | 0.89 | 0.86 | 0.83 |
| Average Basic Shares Outstanding | 748.02M | 751.53M | 751.21M | 749.76M | 747.39M |
| Average Diluted Shares Outstanding | 796.15M | 804.11M | 807.12M | 806.79M | 804.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |